2021 Tumor Markers 2021: Unlocking Mystery of the Genetic Basis of Cancer--US, Europe, Japan--Suppliers Shares and Market Segment Forecasts by Tumor Marker and Country, Competitive Intelligence, Technological Breakthroughs, Emerging Tests

This new seven-country study from VPGMarketResearch contains 1,050 pages, 96 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. 

Highlights

- Business and technological trends in seven major markets: France, Germany, Italy, Japan, Spain,
  UK, and US
- Five-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Profiles of market players and start-up firms developing innovative technologies
  and products
- Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.  The next five years will witness significant developments in reagent systems and automation, as well as an introduction of a wide range of new products that will require innovative marketing approaches.  The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.  Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage

- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA

Worldwide Market Overview

- Laboratories performing DNA sequencing and molecular diagnostic testing by country and market
  segment.

- Five-year test volume and sales projections by country.

Market Segmentation Analysis

- Sales and market shares of major suppliers of molecular diagnostic reagent kits and components.

- Five-year test volume and sales forecasts for major applications, including:

- Infectious Diseases        - Forensic Testing
- Cancer                          - Paternity Testing/HLA Typing
- Genetic Diseases           - Others

- Five-year test volume and sales projections for over 30 NAT assays.

- A comprehensive analysis of the sequencing market, by country and laboratory segment,
  including:

- Industrial        - Academic
- Government   - Commercial

- Detailed market segmentation analysis, including review of the market dynamics, trends,
  structure, size, growth and major suppliers, by country.

Product/Technology Review

- Comparison of leading molecular diagnostic analyzers from Abbott, Beckman Coulter, BD,
  Bio-Rad, Gen-Probe, Roche, Tecan and other suppliers.

- Extensive review of molecular diagnostic technologies, test formats, detection methodologies,
  trends in testing automation and over 30 target/signal amplification methods, including:

- PCR     - bDNA
- SDA     - NASBA
- TMA    - SSSR, and others
- LCR

- Worldwide listings of companies, universities and research centers developing new molecular-
   diagnostic technologies and products.

Competitive Assessments

- Extensive strategic assessments of major suppliers and emerging market entrants,
  including their sales, product portfolios, marketing tactics, collaborative arrangements and
  new technologies/products in R&D.

- Comprehensive listings of companies developing and marketing molecular diagnostics products,
  by test and application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal
  during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

- Business planning issues and concerns.

Methodology

This report is based on a combination of primary and secondary information sources, including interviews with laboratory directors and executives of leading diagnostic companies and start-up firms developing innovative technologies and products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearch’s proprietary data base was conducted.

Contains 1,050 pages and 96 tables

 Introduction
 Worldwide Market and Technology Overview
 A. Cancer Statistics and Etiology
 1. Bladder
 2. Breast
 3. Cervical
 4. Colon and Rectum
 5. Endometrial
 6. Esophagus
 7. Head and Neck
 8. Leukemia
 9. Lung
 10. Lymphoma
 11. Oral
 12. Ovarian
 13. Prostate
 14. Renal Cell Carcinoma
 15. Skin
 16. Stomach
 17. Uterine
 B. Major Current And Emerging Tumor Marker
 1. Introduction
 2. Tumor Marker Classification
 3. ACTH
 4. Alpha-Fetoprotein (AFP)
 5. Beta-2 Microglobulin
 6. CA 15-3/27.29
 7. CA 19-9
 8. CA-125
 9. Calcitonin
 10. Carcinoembrionic Antigen (CEA)
 11. Estrogen and Progesterone Receptors
 12. Ferritin
 13. Gastrin
 14. Human Chorionic Gonadotropin (HCG)
 15. Insulin
 16. Lymphocytes CD4/CD8
 
 17. NSE
 18. Occult Blood
 19. PAP Smear/HPV
 20. Prostatic Acid Phosphatase (PAP)
 21. Prostate-Specific Antigen (PSA)
 22. Squamous Cell Carcinoma Antigen (SCC)
 23. TdT
 24. Thyroglobulin
 25. Tissue Polypeptide Antigen (TPA)
 26. Biochemical Tumor Markers
 - ADA
 - B-Protein
 - PNP
 - 5-Nucleotidase
 27. Oncogenes
 - Abl/abl-bcr
 - AIB1
 - APC
 - BTA 26
 - BCL-2
 - BCR-ABL
 - B-raf
 - BRCA
 - CD44
 - CDK
 - C-abl
 - C-fos
 - C-myb
 - C-myc
 - CYCD1
 - CYP-17
 - DPC
 - E-myc
 - Erb-B
 - HER-2/neu
 - HPC1
 - HSTF
 - L-myc
 - MET
 - MSH
 - NEU
 - N-myc
 
 - N-telopeptide
 - PCA3
 - PIK3CA
 - PTI-1
 - P10
 - P40
 - P51
 ? P53
 ? Ras
 ? Reg
 ? RET
 ? sFas
 ? Sis
 - Src
 28. Polypeptide Growth Factors
 ? Basic Fibroblast Growth Factor
 ? Beta-TGF
 - Cachectin (TNT)
 ? Calmodulin
 ? ECFR
 ? Nerve Growth Factor (NGF)
 ? Epidermal Growth Factor (EGF)
 ? Ornithine Decarboxylase
 ? Transferrin
 ? Transforming Growth Factor-Alpha
 29. Ectopic Hormones
 30. Colony Stimulating Factors
 31. Lymphokines
 ? Alpha-Interferon
 ? B Cell Growth Factors
 ? B Cell Growth Factor (BCGF)
 ? Gamma-Interferon
 ? Interleukin-1 (IL-1)
 ? Macrophage Activating Factor
 32. Immunohistochemical Stains
 33. Emerging Tumor Markers
 ? N-Acetylglucosamine
 ? Actin
 ? Alpha-Actin
 ? Angiogenin
 ? Angiostatin
 ? Antineuronal Antibodies
 
 - 7B2
 ? B72.3
 - B-Protein
 ? Bax
 - BCD-F9
 ? BLCA-4
 - Blood Group Antigens A,B,H
 ? BTA
 - CA 50
 ? CA 72-4/TAG-72
 - CA 195
 ? CA-242
 - CA-549
 ? Cadherin
 - CAM 26
 ? CAR-3
 - CD105
 ? Cathepsin-D
 - Chromogranin A and B
 ? Cluster 1 Antigen
 - Cluster-5/5A Antigen
 ? COX Antigen
 - CTA
 ? CU18
 - Cyclin
 ? DR-70
 - DU-PAN-2
 ? Endometrial Bleeding Associated Factor
 - Endostatin
 ? Epithelial Membrane Antigen
 - FDP
 ? Feulgen Hydrolysis
 - Fibronectin
 ? FSH
 - (1->3)-L-fucosyltransferase
 ? Gastrin-Releasing Peptide (GRP)
 - GDCFP-15
 ? Glucagon
 - Glycoamines
 ? H23
 - HAAH
 ? hk3
 
 - HPA
 ? HSP27
 - Human Carcinoma Antigen
 ? ICAM
 - Intermediate Filaments
 - Cytokeratins/CK18/Cyfra 21-1
 - Desmin
 - Gliofibrillary Acid Protein
 - Neurofilaments
 - Vimentin
 ? KA 93
 - Kallikrein
 - Kinases
 ? KP16D3
 - LAI
 ? Leukocyte Common Antigen
 - Lewis Antigens
 ? Lysophosphatidic Acid (LPA)
 - Ma 695/Ma 552
 ? MABDF3
 - MAG
 ? ME1
 - Minactivin
 ? MN/CA9
 - MSA
 ? Mucin Cancer Antigen (MCA)
 - Multiple Tumor Suppressor 1
 ? Myosin
 - NEA-130
 ? NMP22
 - Nucleolar
 - OA-519
 ? Opiod Peptides
 - P-glycoprotein
 ? Pancreatic Oncofetal Antigen (POA)
 - Parathyrcoid Hormone
 ? Placental Lactogen
 - PR92
 ? Proliferative Index, Ki-67
 - Px
 ? RB Inactivation/Deletion
 
 
 - Ret
 ? S-100 Protein
 - SCCL 175
 ? Selectin
 - Serotonin
 ? Sialic Acid
 - Sialyl SSEA-1/SLX
 ? SN10
 - Somatostatin
 ? TA-90
 - TABA
 ? Tachykinin
 - TAG 12
 ? TPS
 - Troponin
 ? Tubulin
 - VCAM
 ? VEGF
 - Villen
 - White Blood Cell Markers
 C. Instrumentation Review And
 Market Needs
 1. Abbott AxSYM
 2. Abbott IMx
 3. Anagen AN2000/AuraFlex
 4. Beckman Coulter Access
 5. BioChem Pharma SR1
 6. bioMerieux Vidas Series
 7. Biotrol Systems 7000
 8. J&J Diagnostics/Amersham Amerlite
 9. J&J Diagnostics Vitros ECI
 10. Olympus PK Series
 11. Roche Cobas Core
 12. Roche Elecsys
 13. Roche ES 22
 14. Roche ES 33
 15. Roche ES 300/300 AL
 16. Siemens ACS: 180
 17. Siemens ACS: Centaur
 18. Siemens ELISA Processor II/III
 19. Siemens Immuno 1
 20. Siemens/Opus/Plus/Magnum
 
 21. Siemens Stratus
 22. Tosoh AIA Series
 23. Wallac/Pharmacia Delfia
 D. Current and Emerging Technologies
 1. Monoclonal and Polyclonal Antibodies
 2. Immunoassays
 a. Technological Principle
 b. Radioimmunoassay (RIA)
 c. Enzyme Immunoassays (EIA)
 - Overview
 - ELISA
 - Immunofiltration
 - Particle-Membrane Capture Immunoassay
 - Enzyme Amplification
 d. Fluorescent Immunoassays
 e. Luminescence
 - Chemiluminescence
 - Bioluminescence
 3. Molecular Diagnostics
 a. Technology Overview
 b. Amplification Methods
 - PCR
 - DAP-PCR
 - Immuno-PCR
 - QC-PCR
 - CAR
 - DNA
 - HPA
 - LCR
 - NASBA
 - QBR
 - SDA
 - 3 SR, and others
 4. Biochips/Microarrays
 5. Chromosome Analysis
 a. Chronic Myelogenous Leukemia (CML)
 b. Acute Myeloid Leukemia (AML)
 c. Acute Lymphoblastic Leukemia (ALL)
 d. Malignant Lymphomas
 Lymphoid Malignancies
 e. Chronic Lymphocytic Leukemia (CLL)
 f. Solid Cancers
 g. Chromosomal Translocation and Oncogenes
 
 6. Microcomputers and Automation
 7. Artificial Intelligence
 8. Flow Cytometry
 9. Biosensors
 E. Competing/Complementing Technologies
 1. CT
 2. MRI
 3. NMR
 4. PET
 5.Photonics Spectroscopy
 F. Business Environment
 1. Worldwide Market Structure
 2. Worldwide Market Size and Growth
 G. Personal Testing
 France
 A. Executive Summary
 B. Business Environment
 C. Market Structure
 D. Market Size, Growth and Major Suppliers
 Germany
 A. Executive Summary
 B. Business Environment
 C. Market Structure
 D. Market Size, Growth and Major Suppliers
 Italy
 A. Executive Summary
 B. Business Environment
 C. Market Structure
 D. Market Size, Growth and Major Suppliers
 Japan
 A. Executive Summary
 B. Business Environment
 C. Market Structure
 D. Market Size, Growth and Major Suppliers
 
 Spain
 A. Executive Summary
 B. Business Environment
 C. Market Structure
 D. Market Size, Growth and Major Suppliers
 U.K.
 A. Executive Summary
 B. Business Environment
 C. Market Structure
 D. Market Size, Growth and Major Suppliers
 U.S.A.
 A. Executive Summary
 B. Business Environment
 1. Health Care Expenditures
 2. Cost Consciousness
 3. Reimbursement
 4. Industry Consolidation
 5. Managed Care
 a. HMO
 b. PPO
 6. Hospitals
 7. Admissions
 8. Length of Stay
 9. Industry Diversification
 10. Physician Demographics
 11. Population Aging
 a. Chronic Illness
 b. Disease Incidence
 c. Susceptibility to Iatrogenesis
 d. Multiple Illness Cases
 12. Laboratory Regulations
 13. FDA Reform
 C. Market Structure
 1. Centralized Testing
 a. Hospitals
 b. Commercial/Private Laboratories
 2. POT/Decentralized Testing
 a. Physician Offices/Group Practices
 
 b. Cancer Clinics
 c. Other Decentralized Testing Locations
 D. Market Size, Growth and Major Suppliers Sales,
 Instrument Placements and Market Shares
 Major Product Development Opportunities
 A. Reagent Kits and Test Systems/Panels
 B. Instrumentation
 C. Computers, Software and Automation
 D. Auxiliary Products
 Design Criteria for Decentralized Testing Products
 Alternative Market Penetration Strategies
 A. Internal Development
 B. Collaborative Arrangements
 C. University Contracts
 D. Distribution Strategies
 1. Marketing Approaches
 2. Product Complexity
 3. Customer Preference
 4. Established Suppliers
 5. Emerging Suppliers
 6. Major Types of Distributors
 7. Market Segmentation Factor
 Potential Market Entry Barriers and Risks
 A. Market Maturity
 B. Cost Containment
 C. Competition
 D. Technological Edge and Limitations
 E. Patent Protection
 F. Regulatory Constraints
 G. Decentralized Testing Market Challenges
 
 Competitive Profiles
 - Abbott
 - AdnaGen
 - Ambrilia Biopharma
 - AMDL
 - Beckman Coulter
 - Becton Dickinson
 - Biomedical Diagnostics
 - bioMerieux
 - Bio-Rad
 - CanAG Diagnostics
 - CeMines
 - Cepheid
 - Correlogic Systems
 - Dako
 - Decode
 - Diadexus
 - Diagnocure
 - Diasorin
 - Eiken Chemical
 - Enterix
 - Enzo Biochem
 - Epigenomics
 - Exact Sciences
 - Fujirebio
 - Gen-Probe
 - Guided Therapeutics
 - Hologic
 - Ipsogen
 - J&J Diagnostics
 - Kreatech
 - Kyowa Medex
 - Mackay Life Sciences
 - Matritech
 - Myriad Genetics
 - OncoLab
 - Panacea Pharmaceuticals
 - Polartechnics
 - Polymedco
 - PreMD
 - Qiagen
 
 - Radient Pharmaceuticals
 - Roche
 - Scienion
 - Sequenom
 - Siemens Healthcare
 - Takara Bio
 - Targeted Diagnostics & Therapeutics
 - Tosoh
 - Veridex
 - Wako Pure Chemicals
 - Wallac
 - Zila
 
 Appendixes
 Appendix I: Major Companies Developing or
 Marketing Tumor Marker Reagents
 and Instruments
 Appendix II: Major Universities and Research
 Centers Developing Tumor Marker
 Detection
 Technologies and Applications
 Appendix III: Assumed Currency Exchange Rates

List Of Tables

 Tumor Marker Classification

Major Companies Developing or Marketing

ACTH Tests
Major Companies Developing or Marketing
AFP Tests
Major Companies Developing or Marketing
Beta-2 Microglobulin Tests
Major Companies Developing or Marketing
CA 15-3/27.29 Tests
Major Companies Developing or Marketing
CA 19-9 Tests
Major Companies Developing or Marketing
CA 125 Tests
Major Companies Developing or Marketing
Calcitonin Tests
Major Companies Developing or Marketing
CEA Tests
Major Companies Developing or Marketing
Estrogen Receptor Tests
Major Companies Developing or Marketing
Progesterone Receptor Tests
Major Companies Developing or Marketing
Ferritin Tests
Major Companies Developing or Marketing
Gastrin Tests

Major Companies Developing or Marketing
HCG Tests

Major Companies Developing or Marketing
Insulin Tests

Major Companies Developing or Marketing
NSE Tests
Major Companies Developing or Marketing
Occult Blood Tests
Major Companies Developing or Marketing
PAP Smear/HPV Tests
Major Companies Developing or Marketing
PAP Tests
Major Companies Developing or Marketing
PSA Tests
Major Companies Developing or Marketing
Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications
In Cancer Diagnosis
Oncogenes Potential Applications
In Cancer Diagnosis
Major Companies Developing or Marketing
Oncogene Tests
Growth Factors Potential Applications
In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications
In Cancer Diagnosis

Immunohistochemical Stains Potential
Applications in Cancer Diagnosis
Executive Summary Table: France, Total Tumor
Marker Test Volume and Sales Forecast by Market
Segment
France, Estimated Cancer Death Rates
Per 100,000 Population
France, Laboratories Performing Tumor
Marker Tests by Market Segment
France, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
France, Commercial/Private Laboratories
Performing Tumor Markers by Annual
Test Volume
France, Total Tumor Marker Volume
Forecast by Market Segment
France, All Market Segments Major Tumor
Marker Test Volume Forecast
France, Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Test
France, Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
France, Total Tumor Marker Sales Forecast
By Market Segment
France, All Market Segments Major Tumor
Marker Sales Forecast by Test
France, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test

France, Commercial/Private Laboratories
Tumor Marker Market Forecast by Test
France, ACTH Test Volume and Diagnostics Sales
Forecast by Market Segment
France, AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Beta-2 Microglobulin Test Volume and
Diagnostics Sales Forecast by Market Segment

France, CA 15-3/27.29 Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market
France, CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
France, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Colon-Specific Antigen Test Volume
And Diagnostics Sales Forecast by Market
Segment
France, Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market Segment


France, Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market Segment
France, Ferritin Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
France, HCG Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Interferons Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Interleukins Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Lymphocyte Subtyping Test Volume
And Diagnostics Sales Forecast by Market
Segment
France, NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Nucleolar Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Occult Blood Test Volume and
Diagnostics Sales Forecast by Market
Segment

France, Oncogenes Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
France, PAP Smear Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Parathyroid Hormone Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Progesterone Receptor Test Volume
And Diagnostics Sales Forecast by Market
Segment

France, PAP Test Volume and Diagnostics Sales
Forecast by Market Segment
France, PSA Test Volume and Diagnostics Sales
Forecast by Market Segment
France, S-100 Protein Test Volume and Sales
Diagnostics Sales Forecast by Market
Segment
France, Serotonin Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Sialic Acid Test Volume and
Diagnostics Sales Forecast by Market
Segment



France, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
France, TDT Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Thymidine Kinase Test Volume
And Diagnostics Sales Forecast by
Market Segment
France, Thyroglobulin Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, TPA Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Total Tumor Marker Sales
By Major Suppliers
France, AFP Testing Market Diagnostics
Sales by Major Supplier
France, CA 15-3 Testing Market Diagnostics
Sales by Major Supplier
France, CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
France, CA 125 Testing Market Diagnostics
Sales by Major Supplier
France, CEA Testing Market Diagnostics
Sales by Major Supplier
France, NSE Testing Market Diagnostics
Sales by Major Supplier

France, PAP Testing Market Diagnostics
Sales by Major Supplier
France, PSA Testing Market Diagnostics
Sales by Major Supplier
France, Tumor Marker Testing
Instrumentation Major Systems
Estimated Placements and Installed
Base by Supplier and Model
Executive Summary Table: Germany, Total
Tumor Marker Test Volume and Sales Forecast
By Market Segment

Germany, Estimated Cancer Death Rates
Per 100,000 Population
Germany, Laboratories Performing Tumor
Marker Tests by Market Segment
Germany, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Germany, Commercial/Private Laboratories
Performing Tumor Marker Tests by Annual
Volume
Germany, Total Tumor Marker Test Volume
Forecast by Market Segment
Germany, All Market Segments, Major Tumor
Marker Test Volume Forecast
Germany, Hospital Laboratories, Major
Tumor Marker Test Volume Forecast by
Assay

Germany, Commercial/Private Laboratories
Major Tumor Marker Test Volume
Forecast
Germany, Physician Offices/Group
Practices Major Tumor Marker
Test Volume Forecast
Germany, Total Tumor Marker Sales
Forecast by Market Segment
Germany, All Market Segments Major Tumor
Marker Sales Forecast by Assay
Germany, Hospital Laboratories, Major Tumor
Marker Sales Forecast by Test
Germany, Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
Germany, Physician Offices/Group Practices
Major Tumor Marker Sales Forecast by Test
Germany, ACTH Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, AFP Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Beta-2 Microglobulin Test Volume
And Diagnostics Sales Forecast by Market
Segment
Germany, CA-15-3/27.29 Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, CA-19 Test Volume and Diagnostics
Sales Forecast by Market Segment

Germany, CA 125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Calcitonin Test Volume and
Diagnostic Sales Forecast by Market
Segment
Germany, Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
Germany, Colon-Specific Antigen Test Volume
And Diagnostics Sales Forecast by Market
Segment
Germany, Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, HCG, Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Interferons Test Volume and
Diagnostics Sales Forecast by Market
Segment

Germany, Interleukins Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, Lymphocyte Subtyping Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Nucleolar Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Occult Blood Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, Oncogenes Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
Germany, Pap Smear Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, Parathyroid Hormone Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, Progesterone Receptor Test Volume
And Diagnostics Sales Forecast by Market
Segment

Germany, PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, S-100 Protein Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, Serotonin Test Volume and
Diagnostics Sales Forecast by Mar
Segment
Germany, Sialic Acid Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales Forecast
By Market Segment
Germany, TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Thymidine Kinase Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, Thyroglobulin Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Total Tumor Marker Sales
By Major Supplier


Germany, AFP Testing Market Diagnostics
Sales by Major Supplier
Germany CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
Germany CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
Germany, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Germany, CEA Testing Market Diagnostics
Sales by Major Supplier
Germany, PSA Testing Market Diagnostics
Sales by Major Supplier
Germany, Tumor Marker Testing
Instrumentation Major Systems
Estimated Placements and Installed Base
By Supplier and Model
Executive Summary Table: Italy, Total Tumor
Marker Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Estimated Cancer Death Rates
Per 100,000 Population
Italy, Laboratories Performing Tumor
Marker Tests by Market Segment
Italy, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Italy, Commercial/Private Laboratories
Performing Tumor Markers by Annual
Test Volume

Italy, Total Tumor Marker Test Volume
Forecast by Market Segment
Italy, All Market Segments Major Tumor Marker
Test Volume Forecast
Italy, Hospital Laboratories Major Tumor
Marker Test Volume Forecast
Italy, Commercial/Private Laboratories
Major Tumor Marker Test Volume
Forecast
Italy, Total Tumor Marker Market
Forecast by Market Segment
Italy, All Market Segments Major Tumor
Marker Sales Forecast by Test
Italy, Hospital Laboratories Major
Tumor Marker Forecast by Test
Italy, Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by
Test
Italy, ACTH Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, AFP Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Beta-2 Microglobulin Test Volume
And Diagnostics Sales Forecast by
Market Segment
Italy, CA 15-3/27.29 Test Volume and
Diagnostics Sales Forecast by Market
Segment

Italy, CA-19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, CA 125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Colon Specific Antigen Test Volume
And Diagnostics Sales Forecast by Market
Segment
Italy, Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market
Segment
Italy, Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market
Segment
Italy, Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment

Italy, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment

Italy, HCG Test Volume and Diagnostics
Sales Forecast by Market Segment

Italy, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment

Italy, Lymphocyte Subtyping Test Volume
And Diagnostics Sales Forecast by Market
Segment


Italy, NSE Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Occult Blood Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Oncogenes Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Pancreatic Oncofetal Antigen Test
Volume and Diagnostics Sales Forecast by
Market Segment
Italy, PAP Smear Test Volume and
Diagnostics Sales Forecast by Market
Segment
Italy, Parathyroid Hormone Test Volume and
Diagnostics Sales Forecast by Market
Segment
Italy, Progesterone Receptor Test Volume and
Diagnostics Sales Forecast by Market
Segment
Italy, PAP Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, PSA Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, S-100 Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Serotonin Test Volume and
Diagnostics Sales Forecast by Market
Segment


Italy, Sialic Acid Test Volume and
Diagnostics Sales Forecast by Market
Segment
Italy, Squamous Cell Carcinoma Antigen Test
Volume and Diagnostics Sales Forecast by
Market Segment
Italy, TDT Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Thymidine Kinase Test Volume and
Diagnostics Sales Forecast by Market
Segment
Italy, Thyroglobulin Test Volume and
Diagnostics Sales Forecast by Market
Segment
Italy, TPA Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Total Tumor Markers
Sales by Major Supplier
Italy, AFP Testing Market Diagnostics
Sales by Major Supplier
Italy, CEA Testing Market Diagnostics
Sales by Major Supplier
Italy, PSA Testing Market Diagnostics
Sales by Major Supplier
Italy, Tumor Marker Testing Instrumentation
Major Non-Isotopic Systems Estimated
Installed Base by Supplier and Model


Executive Summary Table: Japan, Total Tumor
Marker Test Volume and Sales Forecast by
Market Segment
Japan, Estimated Cancer Death Rates
Per 100,000 Population
Japan, Laboratories Performing Tumor
Marker Tests by Market Segment
Japan, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Commercial/Private Laboratories
Performing Tumor Marker Tests
By Annual Volume
Japan, Total Tumor Marker Test Volume
Forecast by Market Segment
Japan, All Market Segments Major Tumor
Marker Test Volume Forecast
Japan, Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Assay
Japan, Commercial/Private Laboratories Major
Tumor Marker Test Volume Forecast
Japan, Total Tumor Marker Sales
Forecast by Market Segment
Japan, All Market Segments Major Tumor
Marker Sales Forecast by Test
Japan, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
Japan, Commercial/Private Laboratories Major
Tumor Marker Sales Forecast by Test

Japan, ACTH Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, Beta-2 Microglobulin Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, CA 15-3/27.29 Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, CEA Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Chromogranin Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Colon-Specific Antigen Test Volume
And Diagnostics Sales Forecast by Market
Segment



Japan, Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Ferritin Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Gastrin Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, HCG Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Interferons Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Interleukins Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Lymphocyte Subtyping Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, NSE Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, Nucleolar Test Volume and
Diagnostics Sales Forecast by Market
Segment

Japan, Occult Blood Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Oncogenes Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, PAP Smear Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Parathyroid Hormone
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Progesterone Receptor
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, PAP Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, PSA Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, S-100 Protein Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Serotonin Test Volume and
Diagnostics Sales Forecast by Market
Segment

Japan, Sialic Acid Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Thyroglobulin
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, TPA, Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Total Tumor Marker
Sales by Major Supplier
Japan, AFP Testing Market Diagnostics
Sales by Major Supplier
Japan, CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
Japan, CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
Japan, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Japan, Calcitonin Testing Market Diagnostics
Sales by Major Supplier

Japan, CEA Testing Market Diagnostics
Sales by Major Supplier
Japan, NSE Testing Market Diagnostics
Sales by Major Supplier
Japan, PAP Testing Market Diagnostics
Sales by Major Supplier
Japan, PSA Testing Market Diagnostics
Sales by Major Supplier
Japan, Tumor Marker Testing
Instrumentation, Major System
Estimated Placements and Installed Base
By Supplier and Model
Executive Summary Table: Spain, Total
Tumor Marker Test Volume and Sales
Forecast by Market Segment
Spain, Estimated Cancer Death Rates
Per 100,000 Population
Spain, Laboratories Performing Tumor
Marker Tests by Market Segment
Spain, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Spain, Commercial/Private Laboratories
Performing Tumor Markers by
Annual Test Volume
Spain, Total Tumor Marker Test Volume
Forecast by Market Segment
Spain, All Market Segment Major Cancer
Diagnostic Test Volume Forecast

Spain, Hospital Laboratories Major Cancer
Diagnostic Test Volume Forecast by
Test
Spain, Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
Spain, Total Tumor Marker Sales
Forecast by Market Segment
Spain, All Market Segments Major Tumor
Marker Sales Forecast by Test
Spain, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
Spain, Commercial/Private Laboratories Major
Tumor Marker Sales Forecast by Test
Spain, AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
Spain, Beta-2 Microglobulin Test Volume and
Diagnostics Sales Forecast by Market Segment
Spain, CA 15-3 Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment


Spain, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
Spain, Colon-Specific Antigen Test Volume and
Diagnostics Sales Forecast by Market
Segment
Spain, Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market
Segment
Spain, Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Lymphocyte Subtyping
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Occult Blood Test Volume and
Diagnostics Sales Forecast by Market
Segment
Spain, Oncogenes Test Volume and
Diagnostics Sales Forecast by Market
Segment


Spain, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, PAP Smear Test Volume and
Diagnostics Sales Forecast by Market
Segment
Spain, Parathyroid Hormone Test Volume
And Diagnostics Sales Forecast by Market
Segment
Spain, Progesterone Receptor
Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain, PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, S-100 Protein Test Volume
And Diagnostics Sales Forecast by Market
Segment
Spain, Serotonin Test Volume and
Diagnostics Sales Forecast by Market
Segment
Spain, Sialic Acid Test Volume and
Diagnostics Sales Forecast by Market
Segment
Spain, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain, TDT Test Volume and Diagnostics
Sales Forecast by Market Segment

Spain, Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Thyroglobulin
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Total Tumor Marker Sales by
Major Supplier
Spain, AFP Testing Market Diagnostics
Sales by Major Supplier
Spain, CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
Spain, 19-9 Testing Market Diagnostics
Sales by Major Supplier
Spain, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Spain, CEA Testing Market Diagnostics
Sales by Major Supplier
Spain, PSA Testing Market Diagnostics
Sales by Major Supplier
Spain, Tumor Marker Testing Instrumentation
Major Systems Estimated Placements and
Installed Base by Supplier and Model
Executive Summary Table: U.K., Total
Tumor Marker Test Volume and Sales
Forecast by Market Segment

U.K., Estimated Cancer Death Rates
Per 100,000 Population
U.K., Laboratories Performing Tumor
Marker Tests by Market Segment
U.K., Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
U.K., Commercial/Private Laboratories
Performing Tumor Marker Tests by
Annual Test Volume
U.K., Total Tumor Marker Testing Volume
Forecast by Market Segment
U.K., All Market Segments Major
Tumor Marker Test Volume Forecast
U.K., Hospital Laboratories Major
Tumor Marker Test Volume Forecast by
Assay
U.K., Commercial/Private Laboratories
Major Tumor Marker Test Volume
Forecast
U.K., Total Tumor Marker Sales
Forecast by Market Segment

U.K., All Market Segments Major
Tumor Marker Sales Forecast by Test
U.K., Hospital Laboratories Major
Tumor Marker Sales Forecast by Test
U.K., Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by
Test

U.K., ACTH Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K., AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K., Beta-2 Microglobulin Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., CA 15-3/27.29 Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Calcitonin Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., CEA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Colon-Specific Antigen Test Volume
And Diagnostics Sales by Market
Segment
U.K., Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market
Segment


U.K., Ferritin Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Lymphocyte Subtyping Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Occult Blood Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., Oncogenes Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., PAP Smear Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Parathyroid Hormone
Test Volume and Diagnostics
Sales Forecast by Market Segment


U.K., Progesterone Receptor
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., S-100 Protein Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., Serotonin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Sialic Acid Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Thyroglobulin
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., TPA Test Volume and Diagnostics
Sales Forecast by Market Segment


U.K., Total Tumor Marker Sales and
Market Shares Forecast
U.K., CEA Testing Market Diagnostics
Sales by Major Supplier
U.K., PSA Testing Market Diagnostics
Sales by Major Supplier
U.K., Tumor Marker Testing
Instrumentation Major Systems
Estimated Placements and Installed Base
By Supplier and Model
Executive Summary Table: U.S., Total Tumor
Marker Test Volume and Sales Forecast by
Market Segment
U.S., Estimated New Cancer Cases and Deaths

U.S., Estimated Cancer Death Rates
Per 100,000 Population
U.S., Laboratories Performing Tumor
Marker Tests by Market Segment
U.S., Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
U.S., Commercial/Private Laboratories
Performing Tumor Marker Tests by
Annual Test Volume
U.S., Physician Office Laboratories
Performing Tumor Marker Tests by
Practice Size
U.S., Total Tumor Marker Test Volume
Forecast by Market Segment

U.S., All Market Segments Major
Tumor Marker Test Volume Forecast
U.S., Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Test
U.S., Commercial/Private Laboratories
Major Tumor Marker Test Volume
Forecast
U.S., Physician Offices/Group Practices
Major Tumor Marker Test Volume
Forecast
U.S., Cancer Clinics Major Tumor
Marker Test Volume Forecast by Assay
U.S., Total Tumor Marker Sales
Forecast by Market Segment
U.S., All Market Segment Major Tumor
Marker Sales Forecast by Test
U.S., Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
U.S., Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
U.S., Physician Offices/Group Practices
Major Tumor Marker Sales Forecast by Test
U.S., Cancer Clinics Major Tumor
Marker Sales Forecast by Test
U.S., ACTH Test Volume and Diagnostics
Sales Forecast by Market Segment

U.S., AFP Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Beta-2 Microglobulin Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., CA 15-3/27.29 Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Calcitonin Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., CEA Test Volume and Diagnostics
Sales by Market Segment
U.S., Chromogranin Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., Colon-specific Antigen Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market
Segment

U.S., Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Interferons Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., Interleukins Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., Lymphocyte Subtyping Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Nucleolar Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Occult Blood Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., Oncogenes Test Volume and Diagnostics
Sales Forecast by Market Segment

U.S., Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., PAP Smear Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Parathyroid Hormone
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Progesterone Receptor
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., S-100 Protein Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., Serotonin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Sialic Acid Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., TDT Test Volume and Diagnostics
Sales Forecast by Market Segment


U.S., Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Thyroglobulin Test
Volume and Diagnostics
Sales Forecast by Market Segment
U.S., TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Total Tumor Marker Sales
By Major Supplier
U.S., AFP Testing Market Diagnostics
Sales by Major Supplier
U.S., CA 125 Testing Market Diagnostics
Sales by Major Supplier
U.S., CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
U.S., CEA Testing Market Diagnostics
Sales by Major Supplier
U.S., Ferritin Testing Market
Diagnostics Sales by Major Supplier
U.S., HCG Testing Market
Diagnostics Sales by Major Supplier
U.S., Insulin Testing Market
Diagnostics Sales by Major Supplier
U.S., PAP Testing Market Diagnostics
Sales by Major Supplier

U.S., PSA Testing Market Diagnostics
Sales by Major Supplier
U.S., Tumor Marker Testing Instrumentation
Major Systems Estimated Placements and
Installed Base by Supplier and Model

Fill The Form For Sample Request

There is no Reviews available